A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT00500318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Clinical Study to Assess the Effect of Inhaled Aclidinium Bromide (LAS34273) 200 ug on Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe COPD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluated the effect of inhaled aclidinium bromide on exercise endurance and in reducing resting and dynamic lung hyperinflation in patients with moderate to severe COPD. It was 9 weeks in duration, consisting of; a 2-week run-in period, 6 weeks of double-blind treatment, and a 1-week follow-up phone call. All patients meeting the eligibility criteria were randomized to one of two treatment groups: aclidinium bromide or placebo.
Study identification
- NCT ID
- NCT00500318
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 181 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Sep 2010 (Actual)
- Last update posted
- Jan 6, 2017
2007 – 2010
United States locations
- U.S. sites
- 42
- U.S. states
- 20
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 2088 | Jasper | Alabama | 35501 | — |
| Forest Investigative Site 0909 | Phoenix | Arizona | 85006 | — |
| Forest Investigative Site 0957 | Long Beach | California | 90822 | — |
| Forest Investigative Site 0973 | Los Angeles | California | 90073 | — |
| Forest Investigative Site 0887 | Los Angeles | California | 90095-1690 | — |
| Forest Investigative Site 0988 | Sacramento | California | 95817 | — |
| Forest Investigative Site 0885 | Torrance | California | 90502 | — |
| Forest Investigative Site 2663 | Clearwater | Florida | 33756 | — |
| Forest Investigative Site 1030 | Jacksonville | Florida | 32224 | — |
| Forest Investigative Site 0974 | Pensacola | Florida | 32504 | — |
| Forest Investigative Site 0980 | Atlanta | Georgia | 30342 | — |
| Forest Investigative Site 0991 | Atlanta | Georgia | 30342 | — |
| Forest Investigative Site 0987 | Austell | Georgia | 30106 | — |
| Forest Investigative Site 2008 | Marietta | Georgia | 30060 | — |
| Forest Investigative Site 0984 | Iowa City | Iowa | 52242 | — |
| Forest Investigative Site 1080 | Topeka | Kansas | 66606 | — |
| Forest Investigative Site 0898 | Baltimore | Maryland | 21224 | — |
| Forest Investigative Site 0886 | Boston | Massachusetts | 02135 | — |
| Forest Investigative Site 1029 | North Dartmouth | Massachusetts | 02747 | — |
| Forest Investigative Site 0889 | Livonia | Michigan | 48152 | — |
| Forest Investigative Site 2079 | Saint Charles | Missouri | 63301 | — |
| Forest Investigative Site 2071 | Omaha | Nebraska | 68198-2465 | — |
| Forest Investigative Site 0972 | Brooklyn | New York | 11229 | — |
| Forest Investigative Site 0971 | Great Neck | New York | 11023 | — |
| Forest Investigative Site 1114 | New York | New York | 10001 | — |
| Forest Investigative Site 2665 | New York | New York | 10010-7436 | — |
| Forest Investigative Site 2081 | Charlotte | North Carolina | 28207 | — |
| Forest Investigative Site 0688 | Charlotte | North Carolina | 28262 | — |
| Forest Investigative Site 0981 | Toledo | Ohio | 43614 | — |
| Forest Investigative Site 1057 | Hershey | Pennsylvania | 17033 | — |
| Forest Investigative Site 0888 | Philadelphia | Pennsylvania | 19140 | — |
| Forest Investigative Site 0983 | Scranton | Pennsylvania | 18509 | — |
| Forest Investigative Site 2072 | Charleston | South Carolina | 29406 | — |
| Forest Investigative Site 1107 | Columbia | South Carolina | 29201 | — |
| Forest Investigative Site 0979 | Columbia | South Carolina | 29203 | — |
| Forest Investigative Site 1078 | Greenville | South Carolina | 29615 | — |
| Forest Investigative Site 0900 | Spartanburg | South Carolina | 29303 | — |
| Forest Investigative Site 0962 | Nashville | Tennessee | 37232-2650 | — |
| Forest Investigative Site 1082 | Dallas | Texas | 75231 | — |
| Forest Investigative Site 2058 | Dallas | Texas | 75246 | — |
| Forest Investigative Site 0890 | Houston | Texas | 77030 | — |
| Forest Investigative Site 0977 | Midvale | Utah | 84047 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00500318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00500318 live on ClinicalTrials.gov.